Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Solid Tumors Cancer Clinical Trial
NCT03821935 | Phase 1 | Interventional
AbbVie
Sponsored by
AbbVie

Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Recruiting

Male & Female

18 Years +

This study is looking to recruit 260 Participants

The study will determine the recommended Phase 2 dose (RP2D) of ABBV-151 administered as monotherapy and in combination with budigalimab (ABBV-181) as well as to assess the safety, pharmacokinetics (PK), and preliminary efficacy of ABBV-151 alone and in combination with budigalimab. The study will consist of 2 phases: dose escalation and dose expansion.